DNA SEQ Alliance

DNA-SEQ provides an interface that coordinates the efforts of a cross-disciplinary network of companies, individuals, and institutions that can provide oncologists and pharmaceutical companies a more precise methodology to diagnose, treat, and inhibit cancer. The DNA-SEQ Alliance is our collaborative pipeline of companies that assure us a second-to-none intelligence gathering process to inform our final crystallographic analysis. We offer a unique synthesis of science, medicine, and information technology.

Our mission is to reduce the time between emerging science and medical practice by providing oncologists a unique genomic data gathering, analysis and targeting service.

DNA-SEQ provides reports to oncologists to more precisely match the patient’s genomic profile with targeted therapies. The report is designed to both enhance the oncologist’s traditional cancer treatment decisions and to dramatically expand the treatment options that can be offered to the patient.

The precision of our process is sharpened by our focus on crystallography as the optimal methodology to pin point the position of the cancerous mutation within a three-dimensional structure. DNA-SEQ’s crystal structure screen provides unmatched precision for matching a drug to a mutation.